<p>艾朗科動物健康（NYSE:ELAN - 獲取免費報告）在週四發佈給投資者的研究報告中，摩根士丹利將其目標價格從 18.00 美元上調至 22.00 美元。該公司目前對該股票的評級為 “持平”。摩根士丹利的目標價格意味着該股票相較於前一交易日收盤價有 0.97% 的潛在下跌空間。</p>
<p>獲取 <strong>艾朗科動物健康</strong> 的提醒：</p>
<ul>
<li>看漲還是看跌？評估動物健康護理股票</li>
</ul>
<p>其他研究分析師也對該公司發佈了研究報告。摩根大通將艾朗科動物健康的評級從 “中性” 上調至 “增持”，並在 10 月 7 日的研究報告中將其目標價格從 18.00 美元上調至 24.00 美元。瑞銀集團在 11 月 6 日的報告中將艾朗科動物健康的目標價格從 25.00 美元上調至 27.00 美元，並給予該公司 “買入” 評級。Stifel Nicolaus 在 9 月 24 日的研究報告中將艾朗科動物健康的目標價格從 18.00 美元上調至 23.00 美元，並給予該股票 “買入” 評級。巴克萊在 12 月 9 日的研究報告中開始覆蓋艾朗科動物健康的股票，設定了 “增持” 評級和 30.00 美元的目標價格。最後，KeyCorp 在 12 月 10 日的研究報告中重新發布了對艾朗科動物健康的 “增持” 評級。兩位分析師給予該股票 “強烈買入” 評級，七位給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，共識目標價格為 23.78 美元。</p>
<p><strong>獲取我們對艾朗科動物健康的最新分析</strong></p>
<h2>艾朗科動物健康股價上漲 0.6%</h2>
<ul>
<li>Zoetis 宣佈新股息，暗示被低估</li>
</ul>
<p>艾朗科動物健康的股票在週四上漲 0.14 美元，達到 22.22 美元。該公司交易了 1,352,910 股股票，而其平均交易量為 5,835,690 股。該公司的債務與股本比率為 0.59，速動比率為 1.23，流動比率為 2.40。該股票的市值為 110.4 億美元，市盈率為 370.48，市盈增長比率為 3.44，貝塔值為 1.86。該公司的 50 日簡單移動平均線為 21.82 美元，200 日簡單移動平均線為 18.25 美元。艾朗科動物健康的股價在過去一年內最低為 8.02 美元，最高為 23.70 美元。</p>
<p>艾朗科動物健康（NYSE:ELAN - 獲取免費報告）最近在 11 月 5 日發佈了季度財報。該公司報告季度每股收益為 0.19 美元，超出市場共識預期的 0.13 美元，超出幅度為 0.06 美元。該公司季度收入為 11.4 億美元，而市場共識預期為 10.9 億美元。艾朗科動物健康的股本回報率為 7.41%，淨利潤率為 0.78%。該公司的季度收入同比增長 10.4%。在去年同期，該公司每股收益為 0.13 美元。艾朗科動物健康將其 2025 財年的每股收益指導區間設定為 0.910-0.940 美元，2025 年第四季度的指導區間為 0.090-0.120 美元。股票分析師預測艾朗科動物健康在當前年度將發佈 0.91 美元的每股收益。</p>
<h2>艾朗科動物健康的內部買賣</h2>
<ul>
<li>2 只具有重大上行潛力的對沖基金股票</li>
</ul>
<p>在相關消息中，內部人士 Rajeev A. Modi 在 12 月 11 日的交易中購買了 4,500 股艾朗科動物健康的股票。該股票的平均購買價格為每股 21.33 美元，總價值為 95,985.00 美元。交易後，該內部人士直接持有該公司 123,082 股股票，價值約為 2,625,339.06 美元。這代表了他們持股比例的 3.79% 的增加。此次收購在 SEC 的法律文件中披露，相關信息可通過 SEC 網站訪問。此外，首席執行官 Jeffrey N. Simmons 在 12 月 11 日的交易中購買了 22,000 股該公司的股票。該股票的平均購買成本為每股 21.75 美元，總交易額為 478,500.00 美元。收購完成後，首席執行官直接持有該公司 167,000 股股票，價值約為 3,632,250 美元。這代表了他們持股比例的 15.17% 的增加。此次購買的 SEC 文件提供了更多信息。在過去 90 天內，內部人士共購買了價值 937,883 美元的 43,450 股公司股票。公司內部人士持有該股票的比例為 0.89%。</p>
<h2>對艾朗科動物健康的對沖基金看法</h2>
<p>最近幾位大型投資者對 ELAN 的持股進行了調整。SJS Investment Consulting Inc. 在第三季度將其在 Elanco Animal Health 的持股增加了 2,563.5%。SJS Investment Consulting Inc. 目前擁有該公司 1,385 股股票，價值 28,000 美元，此前在上個季度又購買了 1,333 股。Huntington National Bank 在第三季度將其在 Elanco Animal Health 的持股提高了 136.7%。Huntington National Bank 目前擁有該公司 1,882 股股票，價值 38,000 美元，此前在上個季度又購買了 1,087 股。Whittier Trust Co. of Nevada Inc. 在第三季度將其在 Elanco Animal Health 的持股增加了 80.3%。Whittier Trust Co. of Nevada Inc. 目前擁有該公司 2,021 股股票，價值 42,000 美元，此前在上個季度又購買了 900 股。Farther Finance Advisors LLC 在第三季度將其在 Elanco Animal Health 的持股增加了 79.3%。Farther Finance Advisors LLC 目前擁有該公司 2,151 股股票，價值 43,000 美元，此前在上個季度又購買了 951 股。最後，First Horizon Advisors Inc. 在第二季度將其在 Elanco Animal Health 的持股增加了 184.3%。First Horizon Advisors Inc. 目前擁有該公司 3,724 股股票，價值 53,000 美元，此前在上個季度又購買了 2,414 股。對沖基金和其他機構投資者持有該公司 97.48% 的股票。</p>
<h2>關於 Elanco Animal Health</h2>
<p>(獲取免費報告)</p>
<p>Elanco Animal Health Incorporated 是一家動物健康公司，創新、開發、製造和銷售寵物和農場動物的產品。它提供寵物健康疾病預防產品，如驅蟲劑和疫苗產品，保護寵物免受蠕蟲、跳蚤和蜱蟲的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；針對犬貓的疼痛、骨關節炎、耳部感染、心血管和皮膚病的寵物健康治療產品，品牌包括 Galliprant 和 Claro；用於家禽和水產養殖生產的疫苗、抗生素、驅蟲劑及其他產品，以及營養健康產品，包括酶、益生菌和益生元；以及用於反芻動物和豬生產的一系列疫苗、抗生素、植入物、驅蟲劑及其他產品，品牌包括 Rumensin 和 Baytril。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票，而不是 Elanco Animal Health</li>
<li>股票分紅削減發生了，你準備好了嗎？</li>
<li>Dollar General 的轉機可能會在 2026 年推動股票上漲</li>
<li>經紀公司排名在股票選擇中的重要性</li>
<li>不要對 AppLovin 下賭注：反對空頭的理由</li>
<li>加拿大便士股票：它們能讓你致富嗎？</li>
<li>美光的第一季度業績表明 “人工智能泡沫遠未破裂”</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Elanco Animal Health 嗎？</h2>
<p>在考慮 Elanco Animal Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Elanco Animal Health 並不在名單上。</p>
<p>雖然 Elanco Animal Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

ELAN

<p>摩根士丹利將 Elanco Animal Health 的目標股價從 18.00 美元上調至 22.00 美元，維持 “持平” 評級。其他分析師，包括摩根大通和瑞銀，也提高了他們的目標股價，評級範圍從 “買入” 到 “增持”。該股票的共識評級為 “適度買入”，共識目標股價為 23.78 美元。報告顯示內部人士有買入活動，公司高管進行了大量股票收購</p>

<p>Elanco Animal Health (NYSE:ELAN - Get Free Report) had its price objective boosted by stock analysts at Morgan Stanley from $18.00 to $22.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an &#34;equal weight&#34; rating on the stock. Morgan Stanley's target price points to a potential downside of 0.97% from the stock's previous close.</p>
<div class="lb-trans"><p>艾朗科動物健康（NYSE:ELAN - 獲取免費報告）在週四發佈給投資者的研究報告中，摩根士丹利將其目標價格從 18.00 美元上調至 22.00 美元。該公司目前對該股票的評級為 “持平”。摩根士丹利的目標價格意味着該股票相較於前一交易日收盤價有 0.97% 的潛在下跌空間。</p>
</div><p>Get <strong>Elanco Animal Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>艾朗科動物健康</strong> 的提醒：</p>
</div><ul>
<li>Bullish or Bearish? Vetting Animal Health Care Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>看漲還是看跌？評估動物健康護理股票</li>
</ul>
</div><p>Other research analysts have also issued research reports about the company. JPMorgan Chase &amp; Co. raised Elanco Animal Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $18.00 to $24.00 in a research report on Tuesday, October 7th. UBS Group lifted their price target on shares of Elanco Animal Health from $25.00 to $27.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, November 6th. Stifel Nicolaus raised their target price on shares of Elanco Animal Health from $18.00 to $23.00 and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, September 24th. Barclays began coverage on shares of Elanco Animal Health in a research report on Tuesday, December 9th. They set an &#34;overweight&#34; rating and a $30.00 price target on the stock. Finally, KeyCorp reissued an &#34;overweight&#34; rating on shares of Elanco Animal Health in a research note on Wednesday, December 10th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $23.78.</p>
<div class="lb-trans"><p>其他研究分析師也對該公司發佈了研究報告。摩根大通將艾朗科動物健康的評級從 “中性” 上調至 “增持”，並在 10 月 7 日的研究報告中將其目標價格從 18.00 美元上調至 24.00 美元。瑞銀集團在 11 月 6 日的報告中將艾朗科動物健康的目標價格從 25.00 美元上調至 27.00 美元，並給予該公司 “買入” 評級。Stifel Nicolaus 在 9 月 24 日的研究報告中將艾朗科動物健康的目標價格從 18.00 美元上調至 23.00 美元，並給予該股票 “買入” 評級。巴克萊在 12 月 9 日的研究報告中開始覆蓋艾朗科動物健康的股票，設定了 “增持” 評級和 30.00 美元的目標價格。最後，KeyCorp 在 12 月 10 日的研究報告中重新發布了對艾朗科動物健康的 “增持” 評級。兩位分析師給予該股票 “強烈買入” 評級，七位給予 “買入” 評級，三位給予 “持有” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，該股票目前的共識評級為 “適度買入”，共識目標價格為 23.78 美元。</p>
</div><p><strong>Get Our Latest Analysis on Elanco Animal Health</strong></p>
<div class="lb-trans"><p><strong>獲取我們對艾朗科動物健康的最新分析</strong></p>
</div><h2>Elanco Animal Health Trading Up 0.6%</h2>
<div class="lb-trans"><h2>艾朗科動物健康股價上漲 0.6%</h2>
</div><ul>
<li>Zoetis Declares New Dividend, Hinting At Undervaluation</li>
</ul>
<div class="lb-trans"><ul>
<li>Zoetis 宣佈新股息，暗示被低估</li>
</ul>
</div><p>Shares of ELAN stock traded up $0.14 on Thursday, hitting $22.22. 1,352,910 shares of the company's stock traded hands, compared to its average volume of 5,835,690. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.23 and a current ratio of 2.40. The stock has a market capitalization of $11.04 billion, a price-to-earnings ratio of 370.48, a P/E/G ratio of 3.44 and a beta of 1.86. The company's fifty day simple moving average is $21.82 and its 200 day simple moving average is $18.25. Elanco Animal Health has a one year low of $8.02 and a one year high of $23.70.</p>
<div class="lb-trans"><p>艾朗科動物健康的股票在週四上漲 0.14 美元，達到 22.22 美元。該公司交易了 1,352,910 股股票，而其平均交易量為 5,835,690 股。該公司的債務與股本比率為 0.59，速動比率為 1.23，流動比率為 2.40。該股票的市值為 110.4 億美元，市盈率為 370.48，市盈增長比率為 3.44，貝塔值為 1.86。該公司的 50 日簡單移動平均線為 21.82 美元，200 日簡單移動平均線為 18.25 美元。艾朗科動物健康的股價在過去一年內最低為 8.02 美元，最高為 23.70 美元。</p>
</div><p>Elanco Animal Health (NYSE:ELAN - Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.13 by $0.06. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Elanco Animal Health had a return on equity of 7.41% and a net margin of 0.78%.The company's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.13 earnings per share. Elanco Animal Health has set its FY 2025 guidance at 0.910-0.940 EPS and its Q4 2025 guidance at 0.090-0.120 EPS. Equities analysts forecast that Elanco Animal Health will post 0.91 EPS for the current year.</p>
<div class="lb-trans"><p>艾朗科動物健康（NYSE:ELAN - 獲取免費報告）最近在 11 月 5 日發佈了季度財報。該公司報告季度每股收益為 0.19 美元，超出市場共識預期的 0.13 美元，超出幅度為 0.06 美元。該公司季度收入為 11.4 億美元，而市場共識預期為 10.9 億美元。艾朗科動物健康的股本回報率為 7.41%，淨利潤率為 0.78%。該公司的季度收入同比增長 10.4%。在去年同期，該公司每股收益為 0.13 美元。艾朗科動物健康將其 2025 財年的每股收益指導區間設定為 0.910-0.940 美元，2025 年第四季度的指導區間為 0.090-0.120 美元。股票分析師預測艾朗科動物健康在當前年度將發佈 0.91 美元的每股收益。</p>
</div><h2>Insider Buying and Selling at Elanco Animal Health</h2>
<div class="lb-trans"><h2>艾朗科動物健康的內部買賣</h2>
</div><ul>
<li>2 Contrarian Stock Picks With Major Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只具有重大上行潛力的對沖基金股票</li>
</ul>
</div><p>In related news, insider Rajeev A. Modi acquired 4,500 shares of Elanco Animal Health stock in a transaction that occurred on Thursday, December 11th. The stock was bought at an average price of $21.33 per share, with a total value of $95,985.00. Following the transaction, the insider directly owned 123,082 shares in the company, valued at approximately $2,625,339.06. This represents a 3.79% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Jeffrey N. Simmons bought 22,000 shares of the company's stock in a transaction on Thursday, December 11th. The stock was bought at an average cost of $21.75 per share, for a total transaction of $478,500.00. Following the completion of the acquisition, the chief executive officer directly owned 167,000 shares of the company's stock, valued at approximately $3,632,250. This represents a 15.17% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired a total of 43,450 shares of company stock worth $937,883 in the last ninety days. 0.89% of the stock is owned by company insiders.</p>
<div class="lb-trans"><p>在相關消息中，內部人士 Rajeev A. Modi 在 12 月 11 日的交易中購買了 4,500 股艾朗科動物健康的股票。該股票的平均購買價格為每股 21.33 美元，總價值為 95,985.00 美元。交易後，該內部人士直接持有該公司 123,082 股股票，價值約為 2,625,339.06 美元。這代表了他們持股比例的 3.79% 的增加。此次收購在 SEC 的法律文件中披露，相關信息可通過 SEC 網站訪問。此外，首席執行官 Jeffrey N. Simmons 在 12 月 11 日的交易中購買了 22,000 股該公司的股票。該股票的平均購買成本為每股 21.75 美元，總交易額為 478,500.00 美元。收購完成後，首席執行官直接持有該公司 167,000 股股票，價值約為 3,632,250 美元。這代表了他們持股比例的 15.17% 的增加。此次購買的 SEC 文件提供了更多信息。在過去 90 天內，內部人士共購買了價值 937,883 美元的 43,450 股公司股票。公司內部人士持有該股票的比例為 0.89%。</p>
</div><h2>Hedge Funds Weigh In On Elanco Animal Health</h2>
<div class="lb-trans"><h2>對艾朗科動物健康的對沖基金看法</h2>
</div><p>Several large investors have recently modified their holdings of ELAN. SJS Investment Consulting Inc. boosted its stake in Elanco Animal Health by 2,563.5% in the 3rd quarter. SJS Investment Consulting Inc. now owns 1,385 shares of the company's stock worth $28,000 after purchasing an additional 1,333 shares in the last quarter. Huntington National Bank raised its holdings in Elanco Animal Health by 136.7% in the third quarter. Huntington National Bank now owns 1,882 shares of the company's stock worth $38,000 after buying an additional 1,087 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its stake in shares of Elanco Animal Health by 80.3% in the third quarter. Whittier Trust Co. of Nevada Inc. now owns 2,021 shares of the company's stock worth $42,000 after buying an additional 900 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in shares of Elanco Animal Health by 79.3% during the third quarter. Farther Finance Advisors LLC now owns 2,151 shares of the company's stock valued at $43,000 after buying an additional 951 shares during the last quarter. Finally, First Horizon Advisors Inc. increased its position in shares of Elanco Animal Health by 184.3% during the second quarter. First Horizon Advisors Inc. now owns 3,724 shares of the company's stock valued at $53,000 after acquiring an additional 2,414 shares in the last quarter. Hedge funds and other institutional investors own 97.48% of the company's stock.</p>
<div class="lb-trans"><p>最近幾位大型投資者對 ELAN 的持股進行了調整。SJS Investment Consulting Inc. 在第三季度將其在 Elanco Animal Health 的持股增加了 2,563.5%。SJS Investment Consulting Inc. 目前擁有該公司 1,385 股股票，價值 28,000 美元，此前在上個季度又購買了 1,333 股。Huntington National Bank 在第三季度將其在 Elanco Animal Health 的持股提高了 136.7%。Huntington National Bank 目前擁有該公司 1,882 股股票，價值 38,000 美元，此前在上個季度又購買了 1,087 股。Whittier Trust Co. of Nevada Inc. 在第三季度將其在 Elanco Animal Health 的持股增加了 80.3%。Whittier Trust Co. of Nevada Inc. 目前擁有該公司 2,021 股股票，價值 42,000 美元，此前在上個季度又購買了 900 股。Farther Finance Advisors LLC 在第三季度將其在 Elanco Animal Health 的持股增加了 79.3%。Farther Finance Advisors LLC 目前擁有該公司 2,151 股股票，價值 43,000 美元，此前在上個季度又購買了 951 股。最後，First Horizon Advisors Inc. 在第二季度將其在 Elanco Animal Health 的持股增加了 184.3%。First Horizon Advisors Inc. 目前擁有該公司 3,724 股股票，價值 53,000 美元，此前在上個季度又購買了 2,414 股。對沖基金和其他機構投資者持有該公司 97.48% 的股票。</p>
</div><h2>About Elanco Animal Health</h2>
<div class="lb-trans"><h2>關於 Elanco Animal Health</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(獲取免費報告)</p>
</div><p>Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.</p>
<div class="lb-trans"><p>Elanco Animal Health Incorporated 是一家動物健康公司，創新、開發、製造和銷售寵物和農場動物的產品。它提供寵物健康疾病預防產品，如驅蟲劑和疫苗產品，保護寵物免受蠕蟲、跳蚤和蜱蟲的侵害，品牌包括 Seresto、Advantage、Advantix 和 Advocate；針對犬貓的疼痛、骨關節炎、耳部感染、心血管和皮膚病的寵物健康治療產品，品牌包括 Galliprant 和 Claro；用於家禽和水產養殖生產的疫苗、抗生素、驅蟲劑及其他產品，以及營養健康產品，包括酶、益生菌和益生元；以及用於反芻動物和豬生產的一系列疫苗、抗生素、植入物、驅蟲劑及其他產品，品牌包括 Rumensin 和 Baytril。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Elanco Animal Health</li>
<li>Stock Dividend Cuts Happen Are You Ready?</li>
<li>Dollar General's Turnaround Could Send the Stock Higher in 2026</li>
<li>The Significance of Brokerage Rankings in Stock Selection</li>
<li>Don’t Bet Against AppLovin: The Case Against the Shorts</li>
<li>Canadian Penny Stocks: Can They Make You Rich?</li>
<li>Micron’s Q1 Results Say “AI Bubble Is Far From Bursting”</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，而不是 Elanco Animal Health</li>
<li>股票分紅削減發生了，你準備好了嗎？</li>
<li>Dollar General 的轉機可能會在 2026 年推動股票上漲</li>
<li>經紀公司排名在股票選擇中的重要性</li>
<li>不要對 AppLovin 下賭注：反對空頭的理由</li>
<li>加拿大便士股票：它們能讓你致富嗎？</li>
<li>美光的第一季度業績表明 “人工智能泡沫遠未破裂”</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMQU4" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=ELAN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Elanco Animal Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Elanco Animal Health 嗎？</h2>
</div><p>Before you consider Elanco Animal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Elanco Animal Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elanco Animal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Elanco Animal Health 並不在名單上。</p>
</div><p>While Elanco Animal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Elanco Animal Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Elanco Animal Health（NYSE 代碼：ELAN）的目標股價被上調至 22.00 美元